Vera Therapeutics (Gene Modulation Technology) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Vera Therapeutics (Gene Modulation Technology) General Information

Description

Portfolio of intellectual property for peptide nucleic acid genetic medicine in San Francisco, California.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • San Francisco, CA
  • United States
Primary Industry
Buildings and Property
Other Industries
Biotechnology
Other Healthcare Technology Systems
Acquirer
NeuBase Therapeutics
Corporate Office
  • San Francisco, CA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vera Therapeutics (Gene Modulation Technology) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Vera Therapeutics (Gene Modulation Technology)‘s full profile, request access.

Request a free trial

Vera Therapeutics (Gene Modulation Technology) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Vera Therapeutics (Gene Modulation Technology)‘s full profile, request access.

Request a free trial

Vera Therapeutics (Gene Modulation Technology) FAQs

  • Where is Vera Therapeutics (Gene Modulation Technology) headquartered?

    Vera Therapeutics (Gene Modulation Technology) is headquartered in San Francisco, CA.

  • What industry is Vera Therapeutics (Gene Modulation Technology) in?

    Vera Therapeutics (Gene Modulation Technology)’s primary industry is Buildings and Property.

  • Is Vera Therapeutics (Gene Modulation Technology) a private or public company?

    Vera Therapeutics (Gene Modulation Technology) is a Private company.

  • What is the current valuation of Vera Therapeutics (Gene Modulation Technology)?

    The current valuation of Vera Therapeutics (Gene Modulation Technology) is .

  • What is Vera Therapeutics (Gene Modulation Technology)’s current revenue?

    The current revenue for Vera Therapeutics (Gene Modulation Technology) is .

  • Who are Vera Therapeutics (Gene Modulation Technology)’s investors?

    Vera Therapeutics has invested in Vera Therapeutics (Gene Modulation Technology).

  • When was Vera Therapeutics (Gene Modulation Technology) acquired?

    Vera Therapeutics (Gene Modulation Technology) was acquired on 20-Apr-2021.

  • Who acquired Vera Therapeutics (Gene Modulation Technology)?

    Vera Therapeutics (Gene Modulation Technology) was acquired by NeuBase Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process